Characterization of Human Ovarian Carcinomas in a SCID Mouse Model

This publication has 10 references indexed in Scilit:

• Immunophenotype of Human Ovarian Malignancies (Cystadenocarcinomata and Mixed Müllerian Tumor) Established in SCID Mice
  Experimental and Molecular Pathology, 1997
• Transplantation of a human ovarian cystadenocarcinoma into severe combined immunodeficient (SCID) mice — formation of metastases without significant alteration of the tumour cell phenotype
  International Journal of Experimental Pathology, 1996
• Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma
  Journal of Molecular Medicine, 1996
• The development of a novel immunotherapy model of human ovarian cancer in human PBL-severe combined immunodeficient (SCID) mice
  Clinical and Experimental Immunology, 1995
• Estrogen‐ and androgen‐responsive growth of human ovarian adenocarcinoma heterotransplanted into nude mice
  International Journal of Cancer, 1990
• Intraperitoneal and subcutaneous xenografts of human ovarian carcinoma in nude mice and their potential in experimental therapy
  International Journal of Cancer, 1989
• Establishment and characterisation of three new human ovarian carcinoma cell lines and initial evaluation of their potential in experimental chemotherapy studies
  International Journal of Cancer, 1987
• Cell survival in four ovarian carcinoma xenografts following in vitro exposure to melphalan, cisplatin and cis-diammine-1,1-cyclobutane dicarboxylate platinum II (CBDCA, JM8)
  Cancer Chemotherapy and Pharmacology, 1984
• Comparison of the activity of doxorubicin analogues using colony-forming assays and human xenografts
  Cancer, 1982
• One Hundred and Twenty-Seven Cultured Human Tumor Cell Lines Producing Tumors in Nude Mice23
  JNCI Journal of the National Cancer Institute, 1977